Immunogenicity of hepatitis A vaccine in children with cancer

Pediatric Hematology and Oncology

Volumn 23, Issue 8, 2006, Pages 619-624

  Köksal, Yavuz ^a   Yalçin, Bilgehan ^a   Aydin, G Burça ^a   Sari, Neriman ^a   Yazici, Nalan ^a   Varan, Ali ^a   Kutluk, Tezer ^a   Akyüz, Canan ^a   Büyükpamukçu, Münevver ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cancer; Chemotherapy; Children; Hepatitis A; Vaccine

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNIZATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; LYMPHOMA; MALE; SEROCONVERSION; SEROLOGY; SOLID TUMOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; NEOPLASMS; PROSPECTIVE STUDIES;

EID: 33750475622     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010600907239     Document Type: Article

References (19)

1. Hastings C, Goes C, Wolff LJ. Immunization of the child with cancer. In: Ablin AR, ed. Supportive Care of Children with Cancer, ed. 2. Baltimore, MD: The John Hopkins University Press; 1997:13-22.
2. Akyol H, Sarialioǧlu F, Büyükpamukçu M, et al. Hepatitis-B virus infections in pediatric patients receiving anti-cancer chemotherapy. Turk J Cancer. 1990;20:104-108.
3. Sevinir B, Meral A, Gunay U, Ozkan T, Ozuysal S, Sinirtas M. Increased risk of chronic hepatitis in children with cancer. Med Pediatr Oncol. 2003;40:104-110.
4. Emir S, Buyukpamukcu M, Koseoglu V, et al. Varicella vaccination in children with lymphoma and solid tumors. Med Pediatr Oncol. 2000;35:269.
5. Berberoglu S, Buyukpamukcu M, Sarialioglu F, Akyuz C, Ilhan I. Hepatitis B vaccination in children with cancer. Pediatr Hematol Oncol. 1995;12:171-178.
6. Weitbertg AB, Weitzman SA, Watkinks E, Hinkle C, O'Rourke S, Dienstag JL. Immunogenicity of hepatitis B vaccine in oncology patients receiving chemotherapy. J Clin Oncol. 1985;3:718-722.
7. Emir S, Buyukpamukcu M, Akyuz C, Kutluk T, Guler E, Caglar K. The comparison of antibody response to different hepatitis B vaccines with and without pre-S2 antigen in children with cancer. Pediatr Hematol Oncol. 2002;19:227-233.
8. Gonzales RP, Jolley C. Infections of the liver. In: Rudolph CD, Rudolph AM, Hostetter MK, Lister G, Siegel NJ, eds. Rudolphs Pediatrics, ed. 21. New York: McGraw Hill; 2002:1495-1501.
9. Kanra G, Tezcan S, Badur S, Turkish National Study Team.. Hepatitis A seroprevalence in a random sample of the Turkish population by simultaneous EPI cluster and comparison with surveys in Turkey. Turk J Pediatr. 2002;44:204-210.
10. Leach CT. Hepatitis A in the United States. Pediatr Infect Dis J. 2004;23:551-552.
11. McFarland E. Immunizations for the immunocompromised child. Pediatr Ann. 1999;28:487-496.
12. Sarialioǧlu F, Akyol H, Büyükpamukçu M, et al. A therapeutic problem in pediatric oncology: the risk of HBsAg positivity at the time of diagnosis. Turk J Cancer. 1993;23:27-33.
13. Kumar A, Misra PK, Rana GS, Mehrotra R. Infection with hepatitis A, B, delta, and human immunodeficiency viruses in children receiving cycled cancer chemotherapy. J Med Virol. 1992;37:83-86.
14. Bell BP. Hepatitis A vaccine. Pediatr Infect Dis. 2000;19:1187-1188.
15. Riedemann S, Reinhardt G, Ibarra H, Frosner GG. Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in healthy toddlers and children in Chile. Acta Paediatr. 2004;93:412-414.
16. Ferreira CT, Leite JC, Taniguchi A, Vieira SM, Pereira-Lima J, Silveira TR. Immunogenicity and safety of an inactivated hepatitis a vaccine in children with Down syndrome. J Pediatr Gastroenterol Nutr. 2004;39:337-340.
17. Majda-Stanislawska E, Bednarek M, Kuydowicz J. Immunogenicity of inactivated hepatitis A vaccine in children with chronic liver disease. Pediatr Infect Dis J. 2004;23:571-574.
18. Santagostino E, Gringeri A, Rocino A, Zanetti A, de Biasi R, Mannucci PM. Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophilic patients. Thromb Haemost. 1994;72:508-510.
19. Gunther M, Stark K, Neuhaus R, Reinke P, Schroder K, Bienzle U. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation. 2001;71:477-490.